Abbott Laboratories ABT
News
It’s Draft Day: Damar Hamlin Helps Build the Abbott HeartMates Team
Abbott Laboratories on Pace for Largest Percent Decrease Since October 2023 — Data Talk
Abbott Labs' first-quarter results top estimates amid strong medical-device sales
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
Abbott Gets FDA Approval for TriClip Heart Valve Repair System
Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve
Abbott Laboratories Cartridge Gets FDA Clearance to be Used with Whole Blood
Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside
Abbott Hosts Conference Call for First-Quarter Earnings
Here's what families need to know after a landmark $60 million verdict in baby-formula suit
Enfamil maker vows to fight $60 million baby-formula verdict as stock slides
Abbott Laboratories On Track for Largest Percent Decrease Since October 2023 — Data Talk
Diabetes and Heart Disease: How to Manage Your Risk
Abbott Extends Innovative Health Partnership With Real Madrid and the Real Madrid Foundation
Real-World Data Show Abbott's FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes
Abbott Declares 401st Consecutive Quarterly Dividend
Abbott Laboratories says FDA independent panel votes to approve heart device
Abbott Laboratories Says FDA Independent Panel Votes to Approve Heart Device
FDA Advisory Committee Votes in Favor of Abbott's First-of-Its-Kind TriClip™ System to Treat People With a Leaky Tricuspid Heart Valve